New Covid vaccine: pharmaceutical company KM Biologics Co. will make the serum, “which has an extremely high level of safety,” available in early 2022. It will be used for third doses

New Covid vaccine from Japan

The Japanese pharmaceutical company KM Biologics Co. will be able to make its serum, developed entirely in Japan, available as early as early 2022, ideally available for the administration of third doses to the population, according to the company itself.

“We will soon be able to guarantee a new vaccine with an extremely high level of safety, which we expect to make available to the population by next spring,” company president Toshiaki Nagasato confirmed at a press conference.

Read Also:

“Mu” Variant, First Case Detected In Japan: First Case In Colombia

Long Covid, Half Of Those Cured In Japan With Persistent Disorders

Source:

Agenzia Dire